PUBLISHER: The Business Research Company | PRODUCT CODE: 1760618
PUBLISHER: The Business Research Company | PRODUCT CODE: 1760618
A medical needle-free injection is a device that administers medications or vaccines through the skin using high-pressure technology, eliminating the need for a traditional needle. It works by creating a fine stream of liquid that penetrates the skin, enabling the quick and painless delivery of drugs.
The primary types of medical needle-free injectors include jet-based, spring-based, laser-powered, and vibration-based injectors. Jet-based needle-free injectors use a high-pressure liquid stream to deliver medication through the skin without needles, offering a safer and less painful alternative for administering vaccines and insulin. These injectors can deliver medication in different modes, such as subcutaneous, intramuscular, intradermal (ID), and intravenous (IV), and are used for a variety of applications including vaccine administration, insulin delivery, pain management, oncology treatments, and more. They are utilized by various end-users, including hospitals, clinics, home care settings, research laboratories, and others.
The medical needle free injection market research report is one of a series of new reports from The Business Research Company that provides medical needle free injection market statistics, including the medical needle free injection industry global market size, regional shares, competitors with the medical needle free injection market share, detailed medical needle free injection market segments, market trends, and opportunities, and any further data you may need to thrive in the medical needle free injection industry. This medical needle free injection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The medical needle-free injection market size has grown rapidly in recent years. It will grow from $14.36 billion in 2024 to $16.25 billion in 2025 at a compound annual growth rate (CAGR) of 13.2%. The growth during the historic period can be attributed to several factors, including the rising demand for painless drug delivery, an increase in self-administration of medications, a growing preference for minimally invasive procedures, the expanding adoption of home healthcare solutions, and a higher demand for needle-free alternatives.
The medical needle-free injection market size is expected to see rapid growth in the next few years. It will grow to $26.33 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The projected growth in the forecast period can be attributed to technological advancements in drug delivery systems, rising demand for personalized medicine, an increased focus on patient comfort and convenience, the expansion of the biologics and biosimilars market, and growing healthcare expenditures in emerging economies. Key trends expected during this period include advancements in jet injection technology, the development of more compact and portable devices, innovations in combination drug delivery systems, progress in microneedle technology for painless injections, and the emergence of multi-dose needle-free injectors.
The growing number of diabetes patients is anticipated to drive the expansion of the medical needle-free injection market. Diabetes is a long-term condition where the body struggles to regulate blood glucose levels effectively. The increasing prevalence of diabetes is primarily linked to the rising incidence of obesity, a major risk factor for type 2 diabetes. Needle-free injection systems offer a painless, non-invasive method for administering insulin or other medications using high-pressure technology. These systems reduce pain, ease needle-related anxiety, and improve patient compliance with treatment regimens. For example, according to a June 2024 report from the National Health Service (NHS), a UK-based government agency, 3,615,330 people registered with general practitioners were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023-an 18% increase from 3,065,825 cases in 2022. This rising number of diabetes cases is contributing to the growth of the medical needle-free injection market.
Key players in the medical needle-free injection market are focusing on technological innovations such as jet-based injection systems to enhance drug delivery and increase patient comfort. These systems use high-pressure liquid streams to deliver medication without needles, providing a safer and more comfortable alternative to traditional injections. For instance, in November 2024, Sol-Millennium Medical Group, a US-based medical device manufacturer, introduced the InsuJet needle-free insulin injector in Canada. The device employs high-pressure jet technology to administer insulin without needles, aiming to decrease pain, reduce anxiety, and minimize needle-associated risks, thereby promoting better adherence to treatment.
In May 2024, Serum Institute of India (SII), an India-based biotechnology company, acquired a 20% stake in IntegriMedical for an undisclosed sum. The acquisition is intended to combine SII's vaccine production capabilities with IntegriMedical's expertise in needle-free injection technology, with the goal of accelerating the development and worldwide distribution of safer and more efficient vaccine delivery methods. This partnership aims to enhance patient comfort and reduce needle-related injuries. IntegriMedical is a US-based biotechnology company that specializes in the development and commercialization of needle-free drug delivery systems.
Major players in the medical needle free injection market are Pfizer Inc., Medline Industries LP., Daicel Corporation, AptarGroup Inc., Gerresheimer AG, Portal Instruments, Inovio Pharmaceuticals Inc., PharmaJet Inc., RPK Group, National Medical Products Inc., Mika Medical, Injex Pharma AG, Crossject SA, InsuJet, NuGen Medical Devices Inc., Robbins Instruments, PICOCYL, MIT Canada Inc., AcuShot Needle Free, FlowBeams.
North America was the largest region in the medical needle free injection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in medical needle-free injection report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the medical needle-free injection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The medical needle-free injection market consists of sales of gas-powered needle-free injectors, electroporation-based injectors, transdermal patch systems, and powder injector systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Needle Free Injection Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on medical needle free injection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical needle free injection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical needle free injection market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.